Fenofibrate lowers plasma triglycerides and increases LDL particle diameter in subjects with type 2 diabetes.

Diabetes care

Volumn 25, Issue 3, 2002, Pages 627-628

  Vakkilainen, Juha ^a   Steiner, George ^a   Ansquer, Jean Claude ^a   Perttunen Nio, Hëlina ^a   Taskinen, Marja Riitta ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; FENOFIBRATE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TRIACYLGLYCEROL;

BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETIC ANGIOPATHY; HUMAN; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL;

ANTILIPEMIC AGENTS; CHOLESTEROL, LDL; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; HUMANS; LIPOPROTEINS, LDL; PLACEBOS; PROCETOFEN; TRIGLYCERIDES;

EID: 0036511471     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.3.627     Document Type: Letter

References (0)